OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
61 hedge funds and large institutions have $89M invested in OptiNose in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 16 closing their positions.
118% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 11
0.6% more ownership
Funds ownership: 3.72% → 4.32% (+0.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
2% less funds holding
Funds holding: 62 → 61 (-1)
26% less capital invested
Capital invested by funds: $120M → $89M (-$31.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$5.12M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.94M |
| 3 |
GC
GMT Capital
Atlanta,
Georgia
|
+$1.71M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.61M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Element Capital Management
New York
|
-$639K |
| 2 |
Jane Street
New York
|
-$320K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$263K |
| 4 |
HF
HRT Financial
New York
|
-$226K |
| 5 |
6CM
683 Capital Management
New York
|
-$198K |
OPTN Hedge Fund Activity: Q2 2023 in Review
61 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q2 2023, worth a combined $89M — down 26% from $120M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of OPTN and 15 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 24 added.
The largest buyer was BlackRock, adding an estimated $5.12M. The largest seller was Element Capital Management, exiting entirely with an estimated $639K sold.
- 61 institutional investors held OptiNose (OPTN) as of Q2 2023, down from 62 in Q1 2023.
- Funds reported $89M of OptiNose stock for Q2 2023, down 26% quarter-over-quarter.
- 15 funds opened new OptiNose positions in Q2 2023 and 16 closed out, a net change of -1 holder.
- The largest OptiNose buyer in Q2 2023 was BlackRock, an estimated $5.12M added.
- The largest OptiNose seller in Q2 2023 was Element Capital Management, an estimated $639K sold.
Based on aggregated 13F filings for Q2 2023.